Adial Pharmaceuticals, Inc. (ADIL)
2.13
-0.16
(-6.99%)
USD |
NASDAQ |
Mar 04, 10:09
Adial Pharmaceuticals Free Cash Flow : -6.622M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Acurx Pharmaceuticals, Inc. | -7.853M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Alnylam Pharmaceuticals, Inc. | 465.38M |
| Savara, Inc. | -99.27M |
| BioMarin Pharmaceutical, Inc. | 717.02M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.833M |
| Cash from Financing (Quarterly) | 0.5247M |
| Free Cash Flow Per Share (Quarterly) | -2.067 |
| Free Cash Flow to Equity (Quarterly) | -1.833M |
| Free Cash Flow to Firm (Quarterly) | -1.833M |
| Free Cash Flow Yield | -86.80% |